Share on StockTwits

Equities Research Analysts’ downgrades for Monday, May 26th:

Bio-Rad Laboratories (NYSE:BIO) was downgraded by analysts at TheStreet from a buy rating to a hold rating. The analysts wrote, “Bio-Rad Laboratories (BIO) has been downgraded by TheStreet Ratings from buy to hold. The company’s strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and relatively poor performance when compared with the S&P 500 during the past year.”

Central Federal (NASDAQ:CFBK) was downgraded by analysts at TheStreet from a hold rating to a sell rating. The analysts wrote, “Central Federal (CFBK) has been downgraded by TheStreet Ratings from hold to sell. The area that we feel has been the company’s primary weakness has been its relatively poor performance when compared with the S&P 500 during the past year.”

CIT Group (NYSE:CIT) was downgraded by analysts at TheStreet from a hold rating to a sell rating. The analysts wrote, “CIT Group (CIT) has been downgraded by TheStreet Ratings from hold to sell. The company’s weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and feeble growth in its earnings per share.”

China TechFaith (NASDAQ:CNTF) was downgraded by analysts at TheStreet from a hold rating to a sell rating. The analysts wrote, “China TechFaith Wireless Comm Tech (CNTF) has been downgraded by TheStreet Ratings from hold to sell. The company’s weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and poor profit margins.”

EnLink Midstream (NASDAQ:ENLC) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. They currently have $43.30 target price on the stock.

Investors Capital Holdings (NYSE:ICH) was downgraded by analysts at TheStreet from a hold rating to a sell rating. The analysts wrote, “Investors Capital Holdings (AMEX:ICH) has been downgraded by TheStreet Ratings from hold to sell. The company’s weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and disappointing return on equity.”

I.D. Systems (NASDAQ:IDSY) was downgraded by analysts at TheStreet from a hold rating to a sell rating. The analysts wrote, “I D Systems (IDSY) has been downgraded by TheStreet Ratings from hold to sell. The company’s weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.”

Natural Grocers by Vitamin Cottage (NASDAQ:NGVC) was downgraded by analysts at TheStreet from a hold rating to a sell rating. The analysts wrote, “Natural Grocers by Vitamin Cottage (NGVC) has been downgraded by TheStreet Ratings from hold to sell. The company’s weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself, premium valuation and poor profit margins.”

NetApp (NASDAQ:NTAP) was downgraded by analysts at TheStreet from a buy rating to a hold rating. The analysts wrote, “NetApp (NTAP) has been downgraded by TheStreet Ratings from buy to hold. The company’s strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, expanding profit margins and increase in net income. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and weak operating cash flow.”

Silicon Laboratories (NASDAQ:SLAB) was downgraded by analysts at TheStreet from a buy rating to a hold rating. The analysts wrote, “Silicon Laboratories (SLAB) has been downgraded by TheStreet Ratings from buy to hold. The company’s strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and relatively poor performance when compared with the S&P 500 during the past year.”

SurModics (NASDAQ:SRDX) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. Zacks currently has $18.00 target price on the stock. Zacks’ analyst wrote, “We are downgrading SurModics to Underperform from Neutral following the trimming of the fiscal 2014 revenue guidance by the company while releasing its second quarter results earlier in the month. The company now expects revenues in the range of $56 million-$58.5 million (old guidance: $58 $62 million). The lackluster sales guidance caused estimates to go down. Apart from the disappointing guidance, the company reported lower-than-expected revenues in the second quarter. Revenues also declined from the year- ago quarter hurt by the soft sales of in vitro diagnostics offerings. A slowdown in sales in Europe coupled with a shift in order patterns by a few key customers hurt segmental sales in the quarter. “

Silver Spring Networks (NASDAQ:SSNI) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. The firm currently has $11.30 target price on the stock.

Taomee Holdings (NASDAQ:TAOM) was downgraded by analysts at TheStreet from a buy rating to a hold rating. The analysts wrote, “Taomee Holdings (TAOM) has been downgraded by TheStreet Ratings from buy to hold. The company’s strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company’s earnings per share, deteriorating net income and disappointing return on equity.”

ViaSat (NASDAQ:VSAT) was downgraded by analysts at Zacks from a neutral rating to an underperform rating. The firm currently has $53.00 target price on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.